Evidence map›Paper›PMID 41574368›Full record

ArticleFrontiers in medicine2025

Strengthening translational preclinical research through confirmatory multi-laboratory studies.

Sophia C Rotter, María Arroyo-Araujo, Natascha I Drude, Pasquale Pellegrini, Sebastian Kobold, Günther H S Richter, Oliver J Müller, Dunja Bruder, Lars B Riecken, Björn Gerlach and 6 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sophia C RotterQUEST Center for Responsible Research, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
María Arroyo-AraujoQUEST Center for Responsible Research, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
Natascha I DrudeQUEST Center for Responsible Research, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
Pasquale PellegriniQUEST Center for Responsible Research, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
Sebastian KoboldDivision of Clinical Pharmacology, Ludwig-Maximilians-Universität (LMU) University Hospital, LMU Munich, Munich, Germany.
Günther H S RichterDepartment of Pediatrics, Division of Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Oliver J MüllerDepartment of Internal Medicine V, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
Dunja BruderFaculty of Medicine, Infection Immunology Group, Institute of Medical Microbiology and Hospital Hygiene, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Lars B RieckenLeibniz Institute on Aging, Fritz Lipmann Institute, Jena, Germany.
Björn GerlachInstitute of Psychopharmacology, Central Institute of Mental Health, Mannheim, Germany.
Lena SchulerDepartment of Paediatrics, Children's Cancer Research Centre, Kinderklinik München Schwabing, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Juliane Salbach-HirschMedical Faculty at University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Iman DalloulDivision of Clinical Pharmacology, Ludwig-Maximilians-Universität (LMU) University Hospital, LMU Munich, Munich, Germany.
Sebastian KühnDivision Polymer Biomaterials Science, Leibniz Institute for Polymer Research Dresden, Dresden, Germany.
Juliane C WilckeInstitute for Medical Information Processing, Biometry, and Epidemiology, Faculty of Medicine, LMU Munich, Munich, Germany.
Ulf ToelchQUEST Center for Responsible Research, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Successful translation of promising preclinical findings into clinical application remains challenging. To address the rising concerns of failing clinical trials and the resulting economic, social, and ethical consequences, preclinical confirmatory studies have been proposed to generate sufficiently robust evidence for guiding the decision-making process. In a unique funding call, 17 studies in Germany aimed to confirm exploratory findings across various biomedical research fields in a rigorously planned and executed multi-laboratory set-up. Alongside these preclinical research projects, a meta-research project was funded to provide methodological support and collectively investigate confirmatory study design and experimental outcomes. After the first four-year funding period, an in-person workshop brought together representatives from the preclinical confirmatory studies to discuss lessons learned. We summarize the outcomes of these stakeholder discussions, highlight common pitfalls, and propose optimization strategies for experimental set-up and project coordination. As a result, we advocate for new roles-such as preclinical research coordinators-and improved rules and regulations in preclinical research to facilitate large-scale academic research projects. Moreover, we highlight that diverse stakeholders must collaborate to effectively integrate confirmatory multi-laboratory studies into the preclinical research ecosystem.

Indexed as

confirmatory studiesexperimental designmulti-laboratory trialspreclinical researchreproducibilitystakeholder engagement

Identifiers

PMID41574368
PMCPMC12819244

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.